Ever bought medicines or cosmetics over the counter? Yes, then you may have walked into one of the 9,800 retail CVS/pharmacy stores of the largest pharmacy healthcare services provider in the U.S.–CVS Health Corporation (CVS - Free Report) . This Rhode Island-based company has more than 900 walk-in medical clinics–CVS/MinuteClinic and currently possesses a customer satisfaction rate of 95%.

Currently, CVS Health has a Zacks Rank #3 (Hold) but that could change following its first quarter 2018 earnings report which has just released.

We have highlighted some of the key details from the just-released announcement below:

Earnings: The Zacks Consensus Estimate remained at $1.39 per share. CVS Health’s adjusted earnings per share of $1.48 outpaced this estimate by 6.5%. On a year-over-year basis, this figure registered a 26.5% growth.

CVS Health Corporation Price and EPS Surprise

Revenues: CVS Health posted revenues of $45.7 billion up 2.6% y/y. However, it lagged the Zacks Consensus Estimate for revenues of $45.8 billion.

Key Stats: For the first quarter CVS Health’s Pharmacy Services segment revenues increased 3.2% year over year to $32.2 billion, while revenues from Retail/LTC segment increased 5.6% year over year to $20.4 billion.

Major Factors: CVS Health witnessed year-over-year growth in Pharmacy Services Segment on the back of growth in pharmacy network and specialty pharmacy volume as well as brand inflation, partially offset by continued price compression and increased generic dispensing. Also, we are encouraged to note that the company has successfully maintained its growth trend in Retail/LTC segment in the reported quarter. The company has reiterated its full-year 2018 adjusted operating profit growth guidance.

Stock Price: Following the earnings release, share prices gained 4.3% in the pre-market trading session.